News

Spago Nanomedical seeks Australian regulatory nod to begin phase I/IIa study of Tumorad-01 to treat cancer

View more

May 25, 2023

PET reveals effects of brain stimulation in coma patients

View more

May 23, 2023

Rosatom-built radiopharmaceuticals production complex in Bolivia starts supplies

View more

Apr 26, 2023

FDA approves Novartis Millburn facility for US commercial production of Pluvicto®

View more

Apr 26, 2023

PET/MRE improves detection of Crohn's disease

View more

Apr 26, 2023

Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer

View more

Apr 26, 2023